OCUL - オキュラ―・セラピュ―ティクス (Ocular Therapeutix Inc.)

OCULのニュース

   Biotech Takeovers Moved at Snail''s Pace in 2nd Quarter  2021/08/30 22:58:41 GuruFocus
Total value of deals was only $3.2 billion Related Stocks: CLVS , DNLI , AZN , MOR , BIIB , LLY , PFE , AMGN , MRK , ALNY , CRSP , ICPT , SRPT , MDGEF , ALBO , BLRX , OCUL ,
   Hydrogel Based Drug Delivery System Market is Expected to Create New Prospects in Near Future, Key Players -Bausch and Lomb, Medtronic, Ocular Therapeutix, Inc.  2021/08/27 12:20:47 OpenPR
New York, United States: Decisive Markets Insights portrays the Hydrogel Based Drug Delivery System MARKET in the best light with its business report. There are several factors at play in the market, which are discussed in depth in the report.
   Dumac, Inc. Buys Roblox Corp, XPeng Inc, Asana Inc, Sells Unity Software Inc, BigCommerce ...  2021/08/24 15:38:29 GuruFocus
Related Stocks: ASAN , PAGS , BAP , RBLX , XPEV , UPST , BABA , PATH , CRWD , U , BIGC , AFRM , BSM , PAM , OCUL ,
   Rubric Capital Management LP Buys Golar LNG, Arconic Corp, Karyopharm Therapeutics Inc, Sells ...  2021/08/17 18:38:09 GuruFocus
Related Stocks: OCUL , TROX , PTVE , PLYA , MORF , RDUS , GLNG , ARNC , KPTI , HMHC , CHMA , HSC , RXT , APO , MIC , THC , USFD , AEL ,
   Tiff Advisory Services Inc Buys Upstart Holdings Inc, Vanguard Financials ETF, Real Estate ...  2021/08/10 06:38:02 GuruFocus
Related Stocks: XLRE , XLU , UPST , VFH , BIGC , NARI , OCUL , VGK , XLK , SUSA ,
   Ocular Therapeutix Announces Termination of the Collaboration with Regeneron to Develop a Sustained-Release Formulation of Aflibercept for the Treatment of Wet AMD and other Serious Retinal Diseases  2021/08/05 20:01:00 Business Wire
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative thera
   Dosing underway in Ocular Therapeutix''s early-stage trial of OTX-TKI for wet AMD  2021/07/29 12:48:20 Seeking Alpha
   Ocular Therapeutix to present clinical data at the 2021 ASCRS Annual Meeting  2021/07/23 13:29:50 Seeking Alpha
   Ocular Therapeutix To Present Clinical Data at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting  2021/07/23 12:00:00 Business Wire
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting being held July 23-27, 2021 in Las Vegas, NV. At ASCRS, we will be presenting data on multiple programs we are advancing in the clinic as w
   Ocular Drug Delivery Global Market Size and Demand by: OCULAR THERAPEUTIX Inc, Alimera Sciences, Allergan PLC, EyeGate Pharma  2021/07/17 09:33:51 Tramways Monthly
Ocular Drug Delivery Market Report fulfills the Current as well as Future aspects and trends. The market study on Global Ocular Drug Delivery Market 2021- 2027 Research Report studies Deep analysis of the Ocular Drug Delivery Market primarily based upon factors on which the companies compete in the market, key trends, and segmentation analysis. Global Ocular []
   Ocular Therapeutix to Participate at Three Upcoming Investor Conferences  2021/05/26 12:00:00 Business Wire
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Jefferies Virtual Healthcare Conference Date: Tuesday, June 1, 2021 Analyst-hosted fireside chat: 4:00 PM ET The JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021 Analyst-hosted f
   Ocular Therapeut (OCUL) falls 0.43% for May 19  2021/05/19 22:00:26 Equities
Ocular Therapeut (NASDAQ: OCUL) shares fell -0.43% to end trading Wednesday at $13.93 per share - a net change of $-0.06. Shares traded between $14.07 and $13.64 throughout the day. 877945 shares of Ocular Therapeut exchanged hands. Visit Ocular Therapeuts profile for more information. About The Nasdaq Stock Market The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world\''s leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. To get more information on Ocular Therapeut and to follow the companys latest updates, you can visit the companys profile page here: Ocular Therapeuts Profile . For more news on the financial markets be sure to visit Equities News . Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by Barchart as of 4:30pm ET on the day of publication.
   Ocular Therapeutix Inc Shares Climb 2.8% Past Previous 52-Week High - Market Mover  2020/12/15 22:30:00 Kwhen Finance
Ocular Therapeutix Inc shares closed 2.8% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 465.1% year-to-date, up 449.8% over the past 12 months, and up 160.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.7%, and the S&P 500 fell 1.2%. Trading Activity Trading volume this week was 42.8% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 28.0% higher than its 20-day moving average, and 101.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio lags its average peer by -100.0% The company's performance over the last 1 year beats its average peer by -5791.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Ocular Therapeutix Inc Shares Climb 7.7% Past Previous 52-Week High - Market Mover  2020/12/14 22:30:00 Kwhen Finance
Ocular Therapeutix Inc shares closed 7.7% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 424.8% year-to-date, up 410.6% over the past 12 months, and up 135.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.0%. Trading Activity Trading volume this week was 32.7% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, Infinity% higher than its 20-day moving average, and 86.8% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio lags its average peer by -100.0% The company's performance over the last 1 year beats its average peer by -4885.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Ocular Therapeutix Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/11 22:30:00 Kwhen Finance
Ocular Therapeutix Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 413.2% year-to-date, up 395.6% over the past 12 months, and up 110.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Trading volume this week was 25.4% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.8% higher than its 5-day moving average, 21.6% higher than its 20-day moving average, and 86.8% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio lags its average peer by -100.0% The company's performance over the last 1 year beats its average peer by -5452.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar